Ranibizumab for the Inhibition of Neovascularization in Pterygia

NCT00768963 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Pterygium

Interventions

DRUG: ranibizumab
DRUG: ranibizumab

Sponsor

University of Miami